158
Participants
Start Date
February 3, 2020
Primary Completion Date
December 29, 2021
Study Completion Date
December 29, 2021
PES-4-BPSD Model
We will conduct a non-randomized preliminary efficacy trial, enrolling N=158 patients (79 control and 79 intervention). The primary outcome will be presence of BPSD as measured by a patient's total score on the Neuropsychiatric Inventory-Questionnaire (NPI-Q) during hospitalization. A multi-modal approach (including chart review and HCG questionnaires) will be used to determine the presence and severity of BPSD.
The attention control condition
On this unit, the management of patients who display BPSD is performed by nurse assistants, rather than PES. Therefore, in order to test the added layer of PES staff, the nurse assistants on the control unit will receive equivalent dementia care education and training as well as staff support (please refer to NCT# 04179721 for more details on this aim).
North Shore University Hospital, Manhasset
Long Island Jewish Medical Center, Glen Oaks
Lead Sponsor
National Institute of Nursing Research (NINR)
NIH
Penn State University
OTHER
Northwell Health
OTHER